BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20339089)

  • 1. Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.
    Steidl C; Telenius A; Shah SP; Farinha P; Barclay L; Boyle M; Connors JM; Horsman DE; Gascoyne RD
    Blood; 2010 Jul; 116(3):418-27. PubMed ID: 20339089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.
    Joos S; Menz CK; Wrobel G; Siebert R; Gesk S; Ohl S; Mechtersheimer G; Trümper L; Möller P; Lichter P; Barth TF
    Blood; 2002 Feb; 99(4):1381-7. PubMed ID: 11830490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma.
    Slovak ML; Bedell V; Hsu YH; Estrine DB; Nowak NJ; Delioukina ML; Weiss LM; Smith DD; Forman SJ
    Clin Cancer Res; 2011 May; 17(10):3443-54. PubMed ID: 21385932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classical Hodgkin lymphoma is associated with frequent gains of 17q.
    Chui DT; Hammond D; Baird M; Shield L; Jackson R; Jarrett RF
    Genes Chromosomes Cancer; 2003 Oct; 38(2):126-36. PubMed ID: 12939740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.
    Steidl C; Diepstra A; Lee T; Chan FC; Farinha P; Tan K; Telenius A; Barclay L; Shah SP; Connors JM; van den Berg A; Gascoyne RD
    Blood; 2012 Oct; 120(17):3530-40. PubMed ID: 22955918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
    Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
    Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.
    Barth TF; Martin-Subero JI; Joos S; Menz CK; Hasel C; Mechtersheimer G; Parwaresch RM; Lichter P; Siebert R; Möoller P
    Blood; 2003 May; 101(9):3681-6. PubMed ID: 12511414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols.
    Greaves W; Xiao L; Sanchez-Espiridion B; Kunkalla K; Dave KS; Liang CS; Singh RR; Younes A; Medeiros LJ; Vega F
    J Hematol Oncol; 2012 Aug; 5():47. PubMed ID: 22871336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
    Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
    Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
    Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
    Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
    Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
    Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.
    Nakashima M; Ishii Y; Watanabe M; Togano T; Umezawa K; Higashihara M; Watanabe T; Horie R
    Cancer Sci; 2010 Nov; 101(11):2490-6. PubMed ID: 20735433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma.
    Otto C; Giefing M; Massow A; Vater I; Gesk S; Schlesner M; Richter J; Klapper W; Hansmann ML; Siebert R; Küppers R
    Br J Haematol; 2012 Jun; 157(6):702-8. PubMed ID: 22469134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
    Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
    Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.
    Janz M; Hummel M; Truss M; Wollert-Wulf B; Mathas S; Jöhrens K; Hagemeier C; Bommert K; Stein H; Dörken B; Bargou RC
    Blood; 2006 Mar; 107(6):2536-9. PubMed ID: 16263788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.
    Sánchez-Espiridión B; Martín-Moreno AM; Montalbán C; Figueroa V; Vega F; Younes A; Medeiros LJ; Alvés FJ; Canales M; Estévez M; Menarguez J; Sabín P; Ruiz-Marcellán MC; Lopez A; Sánchez-Godoy P; Burgos F; Santonja C; López JL; Piris MA; Garcia JF
    Br J Haematol; 2013 Aug; 162(3):336-47. PubMed ID: 23725219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances.
    Franke S; Wlodarska I; Maes B; Vandenberghe P; Delabie J; Hagemeijer A; De Wolf-Peeters C
    Blood; 2001 Mar; 97(6):1845-53. PubMed ID: 11238128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.
    Reichel J; Chadburn A; Rubinstein PG; Giulino-Roth L; Tam W; Liu Y; Gaiolla R; Eng K; Brody J; Inghirami G; Carlo-Stella C; Santoro A; Rahal D; Totonchy J; Elemento O; Cesarman E; Roshal M
    Blood; 2015 Feb; 125(7):1061-72. PubMed ID: 25488972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
    Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.